Development and validation of a ceramide- and phospholipid-based cardiovascular risk estimation score for coronary artery disease patients
Hilvo et al. 2019 Eur Heart J. Published online: 18 June 2019
Lue lisääSusceptibility of low-density lipoprotein particles to aggregate depends on particle lipidome, is modifiable, and associates with future cardiovascular deaths
Ruuth M. et al. 2018 European Heart Journal, 2018: 39 (27),2562–2573.
Lue lisääPlasma concentrations of molecular lipid species predict long-term clinical outcome in coronary artery disease patients
Anroedh et al. 2018 The Journal of Lipid Research. June 1, 2018, doi: 10.1194/jlr.P081281
Lue lisääCeramide stearic to palmitic acid ratio predicts incident diabetes
Hilvo et al. Diabetologia (2018) 61: 1424. https://doi.org/10.1007/s00125-018-4590-6
Lue lisääPCSK9 inhibition alters the lipidome of plasma and lipoprotein fractions
Hilvo et al. 2018 Atherosclerosis Volume 269, Pages 159–165
Lue lisääHigh-grade ovarian serous carcinoma patients exhibit profound alterations in lipid metabolism
Braicu et al. Oncotarget. 2017; 8:102912-102922
Lue lisääCirculating Ceramides Predict Cardiovascular Outcomes in the Population-Based FINRISK 2002 Cohort
Havulinna et al. Arterioscler Thromb Vasc Biol. 2016; 36
Lue lisääPlasma ceramides predict cardiovascular death in patients with stable coronary artery disease and acute coronary syndromes beyond LDL-cholesterol
Laaksonen et al. European Heart Journal, Published online: 28 April 2016
Lue lisääAccumulated Metabolites of Hydroxybutyric Acid Serve as Diagnostic and Prognostic Biomarkers of Ovarian High-Grade Serous Carcinomas
Hilvo et al. Cancer Res. 2016 Feb 15;76(4):796-804
Lue lisääLipidomics: a tool for studies of atherosclerosis
Ekroos K et al. Curr Atheroscler Rep. 2010 Jul;12(4):273-81
Lue lisääDevelopment and validation of a high-throughput LC-MS/MS assay for routine measurement of molecular ceramides
Kauhanen D et al. Anal Bioanal Chem. 2016 May;408(13):3475-83
Lue lisääSTOMPing forward: statins, muscle complaints and CK
Laaksonen R. Atherosclerosis. 2013 Oct;230(2):256-7
Lue lisääBeyond LDL-C lowering: distinct molecular sphingolipids are good indicators of proprotein convertase subtilisin/kexin type 9 (PCSK9) deficiency
Jänis et al. Atherosclerosis 2013 Jun;228(2):380-5
Lue lisääIdentifying new Risk Markers and Potential Targets for Coronary Artery Disease: The Value of the Lipidome and Metabolome
Laaksonen R. Cardiovasc Drugs Ther. 2016 Feb;30(1):19-32
Lue lisääPlasma concentrations of molecular lipid species in relation to coronary plaque characteristics and cardiovascular outcome: Results of the ATHEROREMO-IVUS study
Cheng JM et al. Atherosclerosis 2015 Dec;243(2):560-6.
Lue lisääMolecular lipids identify cardiovascular risk and are efficiently lowered by simvastatin and PCSK9 deficiency
Tarasov K et al. J Clin Endocrinol Metab. 2014 Jan;99(1):E45-52
Lue lisääAlcohol produces distinct hepatic lipidome and eicosanoid signature in lean and obese
Puri P et al. J Lipid Res. 2016 Mar 28
Lue lisääLong-term performance and stability of molecular shotgun lipidomic analysis of human plasma samples
Heiskanen LA et al. Anal Chem. 2013 Sep 17;85(18):8757-63
Lue lisää